Thus, considering CXCR4 and CXCR7 crosstalk in immune cells within the tumor microenvironment, some mechanisms underlying tumor resistance to immunotherapy may be impaired targeting the CXCR4/CXCR7–CXCL12 axis. The gene discussed is CXCL12; the disease is neoplasm.